| | Webinar: Finding the right patients for clinical trials Tuesday, October 5 | 11am ET / 8am PT CROs that embrace these technologies could greatly improve the speed and efficiency of their trials. This webinar will explore the landscape of technologies and services that match patients to clinical trials, providing feedback from CRO executives who have experience with them. Register Now. |
AstraZeneca, others send newly private Cellular on its immuno-oncology path with $120M Labor shortages in healthcare expected to rise as demand grows, report finds Apple Watch's built-in ECG could detect multiple heart arrhythmias, follow-up analysis finds Pharma's 'painful' social media start morphs into refined content strategies across even hipster channels: experts Laurent's COVID-19 pill fails phase 2, but data helps narrow down patients who may benefit Poll: Majority of U.S. voters approve of giving Medicare drug price negotiation authority Fujifilm completes construction of Netherlands production facility, enters validation stage Artificial heart maker SynCardia beamed up by newcomer Picard Medical in VC-engineered deal Researchers unravel the genetic cause of a childhood disorder and a potential way to prevent it with drugs Nurses say hospitals rarely in compliance with OSHA's new COVID-19 protections Fierce Pharma awards best-in-class marketing campaigns in 3rd annual contest—and first live event Featured Story | By Kyle LaHucik Novartis-backed Cellular Biomedicine Group is hitting the ground running as a newly private company with $120 million from AstraZeneca and others after delisting from the Nasdaq in February. read more |
| |
|---|
|
Top Stories By Anastassia Gliadkovskaya The pace of healthcare workers exiting multiple specialties is expected to outpace hiring over the next several years, leading to labor shortages nationwide, Mercer projects. read more By Andrea Park Apple first earned an FDA clearance in 2018 for the electrocardiogram function embedded in the Apple Watch. read more By Beth Snyder Bulik From drab to fab, pharma social media promotions and campaigns are not only getting better but have gotten up to speed with the rest of the marketing world. That’s according to a panel of digital experts at Digital Pharma East this week. While pharma was once hesitant to even try the consumer-driven channels, brands today have adopted sophisticated social strategies along with test-and-learn models across platforms—including even the newest “cool” channels like TikTok and Clubhouse. read more By Annalee Armstrong Another small biotech trying to make a play in COVID-19 treatment has hit a brick wall in clinic trials. This time it’s Laurent Pharmaceuticals, which reported that an oral candidate for hospitalized patients was unsuccessful in a mid-stage trial. read more By Robert King A new poll found a slight majority of U.S. voters approve of giving Medicare the power to negotiate for lower drug prices as negotiations in Congress heat up. read more By Joseph Keenan Fujifilm, which has been on a manufacturing construction tear with the rest of the CDMO industry, has completed building its facility in the Netherlands and now enters the validation stage of the project. Finalization is expected in the coming months. read more By Conor Hale The company takes its inspiration from the eponymous captain of the starship Enterprise, who is known to carry an artificial heart of his own. read more By Kyle LaHucik A UCSD-led team reported a potential way to prevent a newly discovered genetic condition called Zaki syndrome, which impacts the prenatal development of the eyes, brain, hands, kidneys and heart. The researchers found that children born with Zaki had genetic mutations that, in preclinical models, could be successfully targeted with a drug. read more By Dave Muoio A national survey of 5,000 hospital nurses highlighted infrequent PPE and testing during the summer, when OSHA's workplace safety rules went live for front-line workers treating COVID-19 patients. read more By Beth Snyder Bulik Argenx’s deep dive into rare disease myasthenia gravis through patients' eyes swept three categories in the third annual Fierce Pharma Marketing Awards, held on Wednesday night, that celebrated 13 campaigns recognized for best creativity and effectiveness in the third annual contest. read more |
